药明康德:H股公告(刊登發行通函)

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其準確 性或完整性亦不發表任何聲明，並明確表示概不對因本公告全部或任何部分內容而產生或因 倚賴該等內容而引致的任何損失承擔任何責任。
本公告及當中所述上市文件僅按香港聯合交易所有限公司證券上市規則（「上市規則」）規定 刊發以供參考，並不構成任何證券的出售要約或招攬購買要約。本公告或當中所述任何內容（包括上市文件）概非任何合約或承諾的基礎。謹此說明，刊發本公告及當中所述上市文件不 應視為根據發行人（定義見下文）或其代表就香港法例第32章《公司（清盤及雜項條文）條例》而 言刊發的招股章程發售證券，亦並不構成就香港法例第 571章《證券及期貨條例》而言邀請公 眾人士訂立或要約訂立協議收購、處置、認購或包銷證券的廣告、邀請或文件。
本公告並非在美國出售發行人證券的要約，亦非招攬購買發行人證券的要約。本公告所述證 券並無亦不會根據1933年《美國證券法》（經修訂）（「證券法」）或美國任何州的證券法登記，且 不得在美國境內發售或出售，惟根據《美國證券法》豁免或在毋須遵守《美國證券法》的 交易中 進行者除外 。本公告及其所載資料不得直接或間接於或向美國分發。本公告所述證券並無亦 不會在美國公開發售。
致香港投資者通知：發行人及擔保人（定義見下文）確認，債券（定義見下文）僅供專業投資者（定義見上市規則）購買，並已按此基準在香港聯合交易所有限公司上市。因此，發行人及擔 保人確認，債券並不適合香港的零售投資者投資。投資者務請審慎考慮所涉風險。
刊登發行通函
WuXi AppTec (HongKong) Limited
藥明康德（香港）有限公司
（於香港註冊成立的有限公司）
（「發行人」）
由
WUXI APPTEC CO., LTD.*
（無錫藥明康德新藥開發股份有限公司）
（於中華人民共和國註冊成立的股份有限公司）
（股份代號：2359）
（「擔保人」）
無條件及不可撤銷地擔保
500,000,000美元於2025年到期之零息有擔保可轉換債券
（股份代號：5265）
本公告乃根據香港聯合交易所有限公司（「香港聯交所」）上市規則第37.39A條刊發。
茲提述發行人於2024年10月21日所刊發債券於香港聯交所上市的通告。
請參閱本公告隨附日期為2024年10月16日的發行通函（「發行通函」），內容有關500,000,000 美元於 2025年到期之零息有擔保可轉換債券（「債券」）。按發行通函所披露，債券僅供專業投資者（定義見上市規則第37章）購買，並已按此基準在香港聯交所上市。
發行通函並不構成在任何司法權區向公眾人士提呈發售任何證券的招股章程、通告、通函、小冊子或廣告，亦非邀請公眾人士提出認購或購買任何證券的要約，且刊發目的並非邀請公眾人士提出認購或購買任何證券的要約。
香港，2024年10月22日
截至本公告日期，發行人董事會成員包括陳民章博士、胡正國先生、楊青博士、吳皓先生及施明女士。
截至本公告日期，擔保人董事會包括執行董事李革博士、陳民章博士 、胡正國先生、楊青博士及張朝暉先生；非執行董事童小幪先生及吳亦兵博士；以及獨立非執行董事盧韶華女士、俞衛博士、張新博士、詹智玲女士及馮岱先生。
* 僅供識別

NOT FOR DISTRIBUTION TO ANY PERSON OR ADDRESS IN THE UNITED STATES.
IMPORTANT: You must read the following disclaimer before continuing. The following disclaimer applies to the
attached offering circular (the “Offering Circular”). You are therefore advised to read this disclaimer carefully before accessing,
reading or making any other use of the attached Offering Circular. In accessing the attached Offering Circular, you agree to be
bound by the following terms and conditions, including any modifications to them from time to time, each time you receive any
information from the Issuer, the Guarantor (each as defined in the attached Offering Circular) or from Citigroup Global Markets
Limited ( the “Lead Manager”) as a result of such access. In order to review the attached Offering Circular or make an
investment decision with respect to the securities, you must be located outside the United States.
Confirmation of Your Representation: The attached Offering Circular is being sent to you at your request and by
accepting the e-mail and accessing the attached Offering Circular, you shall be deemed to represent to the Issuer, the Guarantor
and the Lead Manager that (1) you are not in the United States and, to the extent you purchase the securities described in the
attached Offering Circular, you will be doing so pursuant to Regulation S under the U.S. Securities Act of 1933, as amended (the
“Securities Act”); (2) the e-mail address that you gave the Issuer and/or the Guarantor and to which this e-mail has been
delivered is not located in the United States, its territories or possessions; (3) you consent to delivery of the attached Offering
Circular and any amendments or supplements thereto by electronic transmission; (4) you (and any nominee and any person on
whose behalf you are subscribing for the securities to which the attached Offering Circular relates) are not a “connected person”
(as defined in the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited (the “Listing
Rules”)) of the Guarantor, which includes but is not limited to any director, chief executive or substantial shareholder of the
Guarantor or any of its subsidiaries or any associate of any of them within the meaning of the Listing Rules; and (5) you (and any
nominee and any person on whose behalf you are subscribing for the securities to which the attached Offering Circular relates)
are, and will immediately after completion of the offering of such securities be, independent of and not acting in concert with,
any of such connected persons in relation to the control of the Guarantor.
The attached Offering Circular has been made available to you in electronic form. You are reminded that documents
transmitted via this medium may be altered or changed during the process of transmission and consequently none of the Issuer,
the Guarantor, the Lead Manager, the Trustee (as defined in the attached Offering Circular) and the Agents (as defined in the
attached Offering Circular) or any of their respective directors, officers, employees, agents, representatives, affiliates or advisers
or any person who controls any of them accepts any liability or responsibility whatsoever in respect